[5] Bell E H , Zhang P , Fisher B J , et al. Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial[J]...
L.; Donati, G.; Lisotti, A.; Campana, D. Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors. Curr. Oncol. 2023, 30, 1381-1394. https://doi.org/10.3390/curroncol30020106 ...
Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors. Curr. Oncol. 2023, 30, 1381-1394. doi.org/10.3390/curronc 发布于 2024-06-24 09:07・江苏 神经内分泌肿瘤 精准医学 替莫唑胺...
Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors. Curr. Oncol. 2023, 30, 1381-1394. doi.org/10.3390/curronc [7]姜琳, 刘绮颖, 贾利晴, 等. 胶质瘤中MGMT甲基化状态及其临床意义的回顾...
Brighi, N.; Lamberti, G.; Andrini, E.; Mosconi, C.; Manuzzi, L.; Donati, G.; Lisotti, A.; Campana, D. Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors. Curr. Oncol. 20...
[6]Brighi, N.; Lamberti, G.; Andrini, E.; Mosconi, C.; Manuzzi, L.; Donati, G.; Lisotti, A.; Campana, D. Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors. Curr. Oncol...
MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblas- toma treated with carmustine wafers. Br J Neurosurg. 2013;27(6): 772-778.Gutenberg A, Bock HC, Bruck W, Doerner L, Mehdorn HM, Roggendorf W, Westphal M, Felsberg J, Reifenberger G, Giese A...
[13]Bell EH, Zhang P, Fisher BJ, et al. Association of MGMT promoter methylation status with survival outcomes in patients with high-risk glioma treated with radiotherapy and temozolomide: an analysis from the NRG oncology...
ConclusionsTime-dependent diffusion MRI–based f in show promise for characterizing MGMT promoter methylation status in newly diagnosed glioblastomas. KEYWORDS: glioblastoma;time-dependent diffusion magnetic resonance imaging;magnetic resonance imaging;microstructure;oscillating gradient spin echo;O 6-methylguanin...
MGMT 基因突变 PROMOTER METHYLATION Allele Registry ID:别名: ClinVar ID: mgmt启动子甲基化已被观察到影响多形性胶质母细胞瘤的肿瘤进展。在出现启动子甲基化的患者中,Akylating试剂卡莫司汀已显示出疗效。在缺乏甲基化的患者中,卡莫司汀和MGMT抑制剂O(6)-苄基鸟嘌呤结合可能有效,但需要更多的实验。临床试验也显...